Product Name:

Fes-pY713+pS716


Product Number:

ab-pk633

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Fes/Fps protein-tyrosine kinase

Target Alias: C-Fes; C-fes/fps protein; Feline sarcoma oncogene; Fes/FPS; FPS; Kinase Fes; Oncogene Fes, feline sarcoma virus; CCDS10365.1; ENSG00000182511

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK633

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y713+S716

Protein UniProt: P07332

Protein SigNET: P07332

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human Fes sequence peptide Cat. No.: PE-04AFT90

Antibody Immunogen Sequence: GV(pY)AA(pS)GGSL(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues G711 to L720; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.

Production Method: Corresponds to amino acid residues G711 to L720; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Medium immunoreactivity of a target-sized protein by Western blotting in HEK-293 cells, which is forskolin-induced and in EGF-treated HeLa cells.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 93-100 kDa.

Antibody Specificity: High

Antibody Cross Reactivity: No significant cross-reactive proteins detected in MCF7 cells, but a medium immunoreactive 150 kDa protein was detected in HEK-293 and HeLa cells.

Scientific Background: Fes is a protein-tyrosine kinase of the TK group and Fer family. It functions downstream of membrane bound receptors and is involved in the regulation of the actin cytoskeleton, microtubule assembly, cell adhesion, and cell spreading. Additionally, Fes plays a role in the degranulation of mast cells and acts downstream of the FCER1 receptor and the mast/stem cell growth factor receptor Kit. In addition, Fes is involved in the regulation of cell differentiation as well as in the promotion of neurite growth in response to nerve growth factor (NGF) signalling. Known targets of the Fes protein include BCR, HCLS1/HS1, PECAM1, STAT3, and TRIM28. Phosphorylation of Y713 increases phosphotransferase activity and interaction with Fes. Fes has been demonstrated to be an oncoprotein in several human cancer types, potentially due to abnormal activation of the kinase catalytic function. It was originally identified as an oncoprotein from avian retroviral (Fps in Fujinami sarcoma virus) and cat retroviral (Fes in feline sarcoma virus) studies. Interestingly, Fes has also been shown to act as a tumour-suppressor protein in some human cancer types. For example, reduced or absent expression of the Fes protein is observed in colon cancer specimens and the ectopic expression of Fes in colon cancer cell lines results in the suppression of anchorage-independent cell growth, indicating a tumour suppressing role for the Fes protein. In contrast, Fes expression is significantly elevated in prostate cancer specimens and is thought to actively promote cell growth in renal carcinoma cell lines. In animal studies, mice lacking Fes expression displayed deficits in hematopoiesis and had significantly reduced numbers of circulating mature myeloid cells and immature myeloid precursors, indicating a oncogenic role for the Fes protein in this cancer.